These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32793282)

  • 1. Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Genet; 2020; 11():726. PubMed ID: 32793282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
    Liu Y; Jia W; Li J; Zhu H; Yu J
    Front Oncol; 2020; 10():587343. PubMed ID: 33117720
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
    Yang L; He Y; Zhang Z; Wang W
    PeerJ; 2019; 7():e8245. PubMed ID: 31844595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
    Zhang D; Zou D; Deng Y; Yang L
    J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
    Ye P; Yang Y; Zhang L; Zheng G
    Front Oncol; 2021; 11():658262. PubMed ID: 34676158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
    Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J
    Front Genet; 2019; 10():1380. PubMed ID: 32117422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events.
    Zhang X; Yin X; Zhang L; Ye Z; Liang G
    Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
    Wu Z; Liu J; Sun R; Chen D; Wang K; Cao C; Xu X
    Front Genet; 2019; 10():1333. PubMed ID: 32063918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.
    Hong W; Zhang W; Guan R; Liang Y; Hu S; Ji Y; Liu M; Lu H; Yu M; Ma L
    Ann Transl Med; 2019 Oct; 7(20):557. PubMed ID: 31807538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alternative splicing events in endometrial cancer prognosis.
    Liu J; Mi C; Long W; Sun T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
    Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
    Front Genet; 2020; 11():534. PubMed ID: 32595697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma.
    Jiang Y; Zhang C; Chen Y; Zhao S; He Y; He J
    Cancer Med; 2023 Feb; 12(4):4895-4906. PubMed ID: 36031798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
    Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
    Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer.
    Xu L; Pan J; Ding Y; Pan H
    Front Genet; 2020; 11():522383. PubMed ID: 33193606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
    Zhang D; Zhang W; Sun R; Huang Z
    Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.